Tokyo-based financial firm investing globally in life science and IT, offering IPO consulting, M&A intermediation, and accounting services.
Location
Tokyo, JP
Founded
1991
Whiz Partners is a Tokyo-based financial firm that invests globally, focusing on life sciences, biotechnology, and information technology sectors. They typically engage in Series B and post-IPO equity rounds, providing substantial capital to growth-stage companies. Their investment strategy spans Japan, the U.S., Europe, and Asia, reflecting a broad geographical reach.
Notable portfolio companies include Caresyntax and Kidswell Bio. Whiz Partners is distinguished by its comprehensive support services, including IPO consulting, M&A intermediation, and corporate management advisory. This holistic approach ensures that portfolio companies receive not only financial backing but also strategic guidance to navigate complex corporate landscapes.
Whiz Partners - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies2
Current Portfolio Count2
Top Investment Stages
Series B1 (100.0%)
Stage Mix
Series B 100%
Concentration shown as share of disclosed investments by stage.
